Last reviewed · How we verify

NCT05241964

Platelet-rich Plasma(PRP) Injection in ED

Status unknown NA Last updated 16 February 2022
What this trial tests

NA trial testing PRP in Erectile Dysfunction in 30 participants. Status unknown.

Timeline
22 March 2021
Primary endpoint
22 September 2022
29 November 2022

Quick facts

Lead sponsorNational Taiwan University Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment30
Start date22 March 2021
Primary completion22 September 2022
Estimated completion29 November 2022
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

National Taiwan University Hospital

Who can join

Adults 20 to 70, male only, with Erectile Dysfunction or PRP. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

RPR contains rich-in growth factors and has the properties of helping tissue regeneration and nerve repair. In theory, it is possibility of curing ED.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of PRP

Trials testing the same drug.

Other recruiting trials for Erectile Dysfunction

Currently open trials in the same condition.

Other National Taiwan University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05241964.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing